Participants enrolling in this retrospective follow-up study will have audiologic and neurodevelopmental assessments obt clinical trials

Study on children treated for CMV infection at birth

This study looks at how well children treated for a virus called CMV at birth have developed. Researchers want to understand if the treatments Ganciclovir and Valganciclovir affected their hearing, learning, and overall health as they grew up. It’s for children aged 2 to 15 years.